Mice Model Market expected to reach USD 1.75 Billion in 2023

According to a new market report published by Transparency Market Research “Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, the global mice model market was valued at USD 1.01 billion in 2013 and is anticipated to expand at a CAGR of 6.4% from 2015 to 2023 to reach USD 1.75 billion by 2023.

Mice have been one of the most important research tools for basic and applied research in biomedical sciences and continues to grow at a rapid rate. Besides providing precise correlation with human condition, the major advantage of mice models is the prospect of exploring precise gene-specific functions and various molecular events in a living organism. Combining mice models with advanced imaging technologies provide unique opportunities to understand the etiology and pathophysiology of human diseases. Furthermore, mice have been widely used in biomedical research to discover human diseases and to evaluate new drug candidates. Mouse research has led to major advances in treating a number of diseases and conditions. For example, experiments on mice models resulted in efficacious treatments for acute promyelocytic leukemia, or APL, which was largely terminal.
 
An expanding collection of gene technology, together with sequencing of the mice genome and biological conservation, place the mouse at the leading position as a model to decode mechanisms underlying human disease progression. More than any other genetically tractable research animal, mice offer a close view of human biology in terms of resemblance with the pathophysiology, cellular structure, and organization. With 99% of their genes shared with humans, new possibilities were opened in genetic testing, drug discovery, and other basic research. Furthermore, the conservation of genetic association within the mice and human genomes with respect to the encoded genes and their alignment along chromosomes has been a great advantage in identification of potentially conforming homologous mutations and disease genes.g healthcare awareness is also propelling the demand for collagen peptide in the regenerative and wound healing markets.

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

The global mice model market has been segmented on the basis of model type, specialty, services, and geography. Based on model type, the market has been segmented into hybrid/congenic, transplantation mouse, transgenic, knockout, carcinogen-induced and spontaneous mouse, outbred, inbred, and conditioned/surgically modified. Inbred was the largest segment of the global mice model market in 2014 due to advantages such as cost effectiveness and data reproducibility. Moreover, the hybrid/congenic segment is expected to expand at the highest CAGR during the forecast period from 2015 to 2023 due to increasing applications in immunology, oncology, and cardiovascular studies. Based on specialty, the market has been segmented into immunology, central nervous system, oncology, cardiovascular, diabetes, and metabolism & regulation. Metabolic & regulatory diseases was the largest specialty segment of the market in terms of revenue in 2014. The diabetes mice models specialty segment is likely to expand at the highest growth rate due to rising prevalence of the disease across the globe, particularly in developed countries. Some of the prominent services offered to end-users include breeding and rederivation, cryopreservation and cryorecovery, quarantine services, genetic testing, model in-licensing, in vivo and in vitro pharmacology services, genetically engineered model services, and other services such as surgical and line rescue. The major factor influencing the growth of the services market is the growing importance of customized models in applied research as well as in the development and production of vital biomolecules.
 
Key players operating in the global mice model market include Charles River Laboratories, Crescendo Biologics Limited, Deltagen, Inc., GenOway S.A., Harlan Laboratories, Inc., ImmunoGenes AG, Taconic Biosciences, Inc., Lexicon Pharmaceuticals, SAGE Labs, The Jackson Laboratory, and TransGenic, Inc.

The global mice model market has been segmented as follows:
 

• Global Mice Model Market, by Type
  • Transgenic Mice Model
  • Hybrid/Congenic Mice Model
  • Knockout Mice Model
  • Carcinogen/induced and Spontaneous Mice Model
  • Outbred Mice Model
  • Inbred Mice Model
  • Transplantation Mice Model
  • Conditioned/Surgically Modified Mice Model
• Global Mice Model Market, by Specialty
  • Immunology
  • Central Nervous System
  • Oncology
  • Cardiovascular
  • Diabetes
  • Metabolism & Regulation
• Global Mice Model Market, by Services
  • Breeding and Rederivation Services
  • Cryopreservation and Cryorecovery Services
  • Quarantine Services
  • Genetic Testing Services
  • Model In-licensing Services
  • In vivo and In vitro Pharmacology Services
  • Other Services (Surgical and Line Rescue)
• Global Mice Model Market, by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific (APAC)
    • Japan
    • China
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & North Africa (MENA)
    • Saudi Arabia
    • UAE
    • Israel
    • Rest of MENA
  • Rest of the World (RoW)

Browse the full Mice Model Market (by Model Type, by Specialty, by Services, and by Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/mice-model-market.html

About Us
 
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
 
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
 
Contact
 
Mr. Nachiket Ghumare
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com